Home / You searched for Nina Warken
It’s now five months since the German Federal Cabinet adopted draft amendments to its pivotal Medizinal-Cannabisgesetzes (MedCanG) bill, and its...
By Dr Sebastian Marincolo, Director of Strategic Content & Editorial, Weed.de Canadian cannabis company Organigram Global has agreed to acquire...
Last month (January 15, 2026) Germany’s Bundesrag held a debate on the hotly contested amendments aimed at significantly restricting medical...
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s...
As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly...
Australia and Germany are moving in opposite directions on medical cannabis imports, as both scramble to deal with the runaway...
Just a week after the first official data on the impact of Germany’s cannabis reforms was published, the Federal Cabinet...
Germany’s booming cannabis market, which Prohibition Partners now estimates to be worth around €670m, is entering uncertain and potentially treacherous...
Telemedicine and access to medical cannabis via online platforms have become a central issue in Germany’s cannabis sector, drawing scrutiny...
Parts of the German federal government are dissatisfied with the current interpretation of the Cannabis Act (CanG), introduced by the...
This article is also available in German Germany’s new Federal Drug Commissioner, Prof Dr Hendrik Streeck (CDU), who in June...
Teile der Bundesregierung in Deutschland stören sich an der derzeitigen Auslegung des Cannabisgesetzes (CanG), das die vorherige Ampel-Koalition auf den...
Während sich der neue Drogenbeauftragte der Bundesregierung, Prof. Dr. Hendrik Streeck (CDU), noch im Juni eher vage bezüglich der Teillegalisierung...
Europe's leading cannabis business summit · 26 May 2026 · 09:00 BST · London